#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erdheim-Chester disease Small intestine neuroendocrine tumour Deafness neurosensory Pouchitis NTRK gene fusion overexpression Malignant neoplasm of choroid Neurofibroma Peripheral primitive neuroectodermal tumour of soft tissue B precursor type acute leukaemia Small cell lung cancer Polyneuropathy Extraskeletal ossification Immune-mediated enterocolitis Systemic scleroderma Frontotemporal dementia More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Basic Information Thrombotic thrombocytopenic purpura – Trials in Disease Glomerulonephritis membranous – Basic Information Basal cell naevus syndrome – Life with Disease Noonan syndrome – Diagnostics Mucopolysaccharidosis I Lysosomal storage disorder – Treatment Tuberous sclerosis complex – Diagnostics Antisynthetase syndrome Mast cell activation syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    89ZR-CED88004S Follitropin Delta GSK4524101A SPY002 Clebopride Hydrogen Maleate Lacutamab Denosumab Epirubicin Hydrochloride Chloride Ion Thiamine Nitrate Bp APAZUNERSEN Omp11 Dipyridamole Cytisine Cannabidiol Egl-001 Vx-670 Ferumoxytol Vindesine Sulfate Resiquimod Sulfate More therapies…

    Learn about Your Condition

    Substance use disorder Thrombectomy Shprintzen-Goldberg syndrome Lymphocytic lymphoma Liposarcoma metastatic Oesophageal cancer metastatic Cholecystitis acute Alveolar proteinosis Hairy cell leukaemia Strongyloidiasis Pulmonary tuberculosis Injection site pain Bacterial infection Leiomyosarcoma metastatic Urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.

    Recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Levosimendan
    Austria Bulgaria Czechia France Germany Hungary +3

  • Using [18F]DED PET imaging to study brain changes in patients with Alzheimer’s disease, CADASIL, and other forms of dementia.

    Recruiting

    2 1 1
    Investigated Diseases:
    • CADASIL
    • Dementia
    • Prodromal Alzheimer’s disease
    Investigated Drugs:
    • [18F]DED
    Spain

  • A Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Belgium Denmark France Germany Italy The Netherlands +2

  • A study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Cardiovascular disorder
    • Chronic kidney disease
    Investigated Drugs:
    • Spironolactone
    • Bi 690517
    • Empagliflozin
    The Netherlands

  • Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Ciltacabtagene Autoleucel
    • Axicabtagene Ciloleucel
    Belgium

  • A study of ACR-368 and gemcitabine for patients with endometrial cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Gemcitabine
    France Germany Italy Spain
Previous Page
1 … 39 40 41 42 43 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!